APEXA BY CEDRA HEALTH Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for APEXA BY CEDRA HEALTH with the United States Patent and Trademark Office. The USPTO has given the APEXA BY CEDRA HEALTH trademark a serial number of 98788682. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, April 10, 2025. The APEXA BY CEDRA HEALTH trademark is filed in the Advertising, Business and Retail Services category with the following description:

retail store services and online retail store services featuring health care products; nutritional products; and pharmaceutical services, namely, processing online prescription orders and preparing pharmaceutical compounds

General Information


Serial Number98788682
Word MarkAPEXA BY CEDRA HEALTH
Filing DateMonday, October 7, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateThursday, April 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesretail store services and online retail store services featuring health care products; nutritional products; and pharmaceutical services, namely, processing online prescription orders and preparing pharmaceutical compounds

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMiami, FL 33160

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Wednesday, April 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 10, 2025ASSIGNED TO EXAMINER